参考文献

1.Cheson BD，Fisher RI，Barrington SF，et al. Recommendations for initial evaluation，staging，and response assessment of Hodgkin and non-Hodgkin lymphoma：the Lugano classification. J Clin Oncol.2014；32（27）：3059-3068.

2.Rai KR，Sawitsky A，Cronkite EP，et al. Clinical staging of chronic lymphocytic leukemia. Blood.1975；46（2）：219-234.

3.Binet JL，Auquier A，Dighiero G，et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer.1981；48（1）：198-206.

4.Olsen E，Vonderheid E，Pimpinelli N，et al. ISCL/EORTC. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome：a proposal of the International Society for Cutaneous Lymphomas（ISCL）and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer（EORTC）.Blood.2007 Sep 15；110（6）：1713-1722.

5.Kim YH，Willemze R，Pimpinelli N，et al. ISCL and the EORTC. TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome：a proposal of the International Society for Cutaneous Lymphomas（ISCL）and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer（EORTC）.Blood.2007 Jul 15；110（2）：479-484.

6.Wolchok JD，Hoos A，O’Day S，et al. Guidelines for the evaluation of immune therapy activity in solid tumors：immune-related response criteria. Clin Cancer Res.2009 Dec 1；15（23）：7412-720.

7.Swerdlow SH，Campo E，Pileri SA，et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood.2016；127（20）：2375-2390.